Literature DB >> 3418734

Surveillance study of diltiazem use in black and nonblack angina patients.

E D Belton, P I Olaya, P Carryon, T Mason, B Harper.   

Abstract

Diltiazem hydrochloride was studied in 133 patients with angina to determine whether differing effects were produced in black patients (39 percent of patients) as compared with nonblack patients. The antihypertensive effect of the drug was also assessed. No statistically significant differences between the responses of blacks and nonblacks were found in the reduction of angina frequency (54 percent of blacks improved, 58 percent of nonblacks), nitroglycerin consumption (60 percent of blacks used less, 66 percent of nonblacks), and changes in lifestyle, as measured with the New York Heart Association scale (55 percent of blacks improved, 63 percent of nonblacks). The antihypertensive effects (not analyzed by race) were greatest in patients with uncontrolled hypertension. Average decreases in this group were 18 mmHg in supine systolic pressures and 14 mmHg in supine diastolic pressures, as compared with decreases of only 4 and 3 mmHg in normotensives. Study results suggest that there is a difference in the type of angina afflicting blacks and nonblacks, that hypertension more often accompanies angina in blacks, and that diltiazem is equally effective in treating angina in blacks and nonblacks.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418734      PMCID: PMC2625775     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  4 in total

1.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Authors:  R S Gibson; W E Boden; P Theroux; H D Strauss; C M Pratt; M Gheorghiade; R J Capone; M H Crawford; R C Schlant; R E Kleiger
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

2.  Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.

Authors:  B Massie; E P MacCarthy; K B Ramanathan; R J Weiss; M Anderson; B A Eidelson; D G Labreche; J F Tubau; D Ulep; D Bartels
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

3.  Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.

Authors:  W H Frishman; E T Zawada; L K Smith; J Sowers; S L Swartz; W Kirkendall; J Lunn; D McCarron; M Moser; H Schnaper
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

4.  Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.

Authors:  P E Pool; B M Massie; K Venkataraman; A T Hirsch; D R Samant; S C Seagren; J Gaw; A F Salel; J F Tubau
Journal:  Am J Cardiol       Date:  1986-02-01       Impact factor: 2.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.